Difference between revisions of "SEIZURES-PHENYTOIN"

From NeuroRehab.wiki

(Imported from text file)
 
(Imported from text file)
 
(One intermediate revision by the same user not shown)
Line 2: Line 2:
1. Effective and well-tried, but no longer 1st line for generalized or partial epilepsy.
1. Effective and well-tried, but no longer 1st line for generalized or partial epilepsy.
<br/>
<br/>
<br/>2. Toxicity - nystagmus, diplopia, tremor, dysarthria, ataxia.
<br/>2. Toxicity: nystagmus, diplopia, tremor, dysarthria, ataxia.
<br/>
<br/>
<br/>3. SEs - decreased intellect, depression, coarse facial features, acne, gum hypertrophy, polyneuropathy, blood dyscrasias.
<br/>3. SEs: decreased intellect, depression, coarse facial features, acne, gum hypertrophy, polyneuropathy, blood dyscrasias.
<br/>
<br/>
<br/>4. Increased clearance - OCP use, pregnancy.
<br/>4. Increased clearance: OCP use, pregnancy.





Latest revision as of 02:29, 21 March 2023

SUMMARY

1. Effective and well-tried, but no longer 1st line for generalized or partial epilepsy.

2. Toxicity: nystagmus, diplopia, tremor, dysarthria, ataxia.

3. SEs: decreased intellect, depression, coarse facial features, acne, gum hypertrophy, polyneuropathy, blood dyscrasias.

4. Increased clearance: OCP use, pregnancy.


Reference(s)

Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. Get it on Amazon.
Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. Get it on Amazon.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].